Keywords:
CP: Biotechnology; CP: Molecular biology; CRISPR; Cas9; HypaCas9; TurboCas9; gene editing; gene therapy; genome modification; off target; protein engineering; synthetic biology
Abstract:
Programmable DNA endonucleases derived from bacterial genetic defense systems, exemplified by CRISPR-Cas9, have made it significantly easier to perform genomic modifications in living cells. However, unprogrammed, off-target modifications can have serious consequences, as they often disrupt the function or regulation of non-targeted genes and compromise the safety of therapeutic gene editing applications.